These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 30879864)

  • 1. Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.
    Almutairi FM; Abd-Rabou AA; Mohamed MS
    Bioorg Med Chem; 2019 Apr; 27(8):1629-1638. PubMed ID: 30879864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines.
    Dhanapal J; Balaraman Ravindrran M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):274-282. PubMed ID: 29298541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
    Wang T; Hou J; Su C; Zhao L; Shi Y
    J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells.
    Abd-Rabou AA; Ahmed HH
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2225-2238. PubMed ID: 31350989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
    Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
    Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy.
    Zou J; Su S; Chen Z; Liang F; Zeng Y; Cen W; Zhang X; Xia Y; Huang D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3456-3464. PubMed ID: 31469318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
    Kumar SP; Birundha K; Kaveri K; Devi KT
    Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.
    Saini D; Fazil M; Ali MM; Baboota S; Ali J
    Drug Deliv; 2015; 22(6):823-36. PubMed ID: 24725026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pursuing for the better lung cancer therapy effect: Comparison of two different kinds of hyaluronic acid and nitroimidazole co-decorated nanomedicines.
    Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L
    Biomed Pharmacother; 2020 May; 125():109988. PubMed ID: 32059173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-decorated redox-sensitive chitosan micelles for tumor-specific intracellular delivery of gambogic acid.
    Xu W; Wang H; Dong L; Zhang P; Mu Y; Cui X; Zhou J; Huo M; Yin T
    Int J Nanomedicine; 2019; 14():4649-4666. PubMed ID: 31303753
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer.
    Lee R; Choi YJ; Jeong MS; Park YI; Motoyama K; Kim MW; Kwon SH; Choi JH
    Bioconjug Chem; 2020 Mar; 31(3):923-932. PubMed ID: 32027493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
    Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
    Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SiRNA/DOX lodeded chitosan based nanoparticles: Development, Characterization and in vitro evaluation on A549 lung cancer cell line.
    Seifi-Najmi M; Hajivalili M; Safaralizadeh R; Sadreddini S; Esmaeili S; Razavi R; Ahmadi M; Mikaeili H; Baradaran B; Shams-Asenjan K; Yousefi M
    Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):87-94. PubMed ID: 27755958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
    Kalam MA
    Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy.
    Zhang X; Niu S; Williams GR; Wu J; Chen X; Zheng H; Zhu LM
    Carbohydr Polym; 2019 Oct; 221():84-93. PubMed ID: 31227170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
    Nokhodi F; Nekoei M; Goodarzi MT
    J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.
    Pandey M; Choudhury H; Gunasegaran TAP; Nathan SS; Md S; Gorain B; Tripathy M; Hussain Z
    Drug Deliv Transl Res; 2019 Apr; 9(2):520-533. PubMed ID: 29488170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.